A. Bumbulienės GLOBOS VAISTINĖ - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 60,140 | 74,924 | 89,537 | 100,674 | 99,805 | 115,220 | 101,834 | 106,107 |
| Profit before tax | -1,719 | 6,102 | 13,309 | 13,738 | 8,814 | 7,973 | 28,439 | -12,860 |
| Net profit | -1,719 | 6,102 | 13,102 | 13,202 | 8,357 | 7,560 | 26,963 | -12,860 |
| Equity | -8,820 | -2,718 | 10,385 | 23,586 | 31,944 | 39,917 | 66,467 | 41,151 |
| Liabilities | - | - | - | - | 48,170 | 40,741 | 34,760 | 26,152 |
| Non-current assets | 8,908 | 7,835 | 30,134 | 7,212 | 5,635 | 5,935 | 5,673 | 5,508 |
| Current assets | 28,992 | 22,806 | 3,218 | 65,635 | 74,479 | 74,723 | 95,554 | 61,795 |
| Total assets | 37,900 | 30,641 | 33,352 | 72,847 | 80,114 | 80,658 | 101,227 | 67,303 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 9,199 | 11,105 | 7,283 |
|
Financial indicators
|
||||||||
| Revenue change y/y | -14.8% | +24.6% | +19.5% | +12.4% | -0.9% | +15.4% | -11.6% | +4.2% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | -4.5% | 19.9% | 39.3% | 18.1% | 10.4% | 9.4% | 26.6% | -19.1% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | - | - | 126.2% | 56.0% | 26.2% | 18.9% | 40.6% | -31.3% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | -2.9% | 8.1% | 14.6% | 13.1% | 8.4% | 6.6% | 26.5% | -12.1% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | -2.9% | 8.1% | 14.9% | 13.6% | 8.8% | 6.9% | 27.9% | -12.1% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | - | - | - | 1.5 | 1.0 | 0.5 | 0.6 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | - | - | - | - | - | - | - |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
A. Bumbulienės GLOBOS VAISTINĖ - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2023-11-03 | 2023-11-30 | 53.53 |
| 2023-10-03 | 2023-10-31 | 53.53 |
| 2023-07-19 | 2023-07-31 | 664.09 |
A. Bumbulienės GLOBOS VAISTINĖ - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
GLOBOS VAISTINE, II, an Individual Enterprise engaged in retail sale of pharmaceutical products, reported revenue of €106.1K in 2025. This was 4.2% higher than in 2024, although revenue remained below the €115.2K achieved in 2023, leaving the two-year change at -7.9%. Profitability weakened markedly in 2025: net loss reached €12.9K, compared with net profit of €27.0K in 2024 and €7.6K in 2023. The 2025 net margin was -12.1%, after 26.5% in 2024 and 6.6% in 2023, indicating a clear deterioration in operating performance during the latest year.
At the end of 2025, total assets were €67.3K, equity €41.2K and liabilities €26.2K. The company’s equity ratio stood at 61.1%, with debt-to-equity at 0.64 and asset turnover at 1.58x. ROE was -31.2% and ROA -19.1%, both reflecting the loss for the year. Compared with 2024, the balance sheet contracted, as assets and equity declined while liabilities also decreased.
At the end of 2025, total assets were €67.3K, equity €41.2K and liabilities €26.2K. The company’s equity ratio stood at 61.1%, with debt-to-equity at 0.64 and asset turnover at 1.58x. ROE was -31.2% and ROA -19.1%, both reflecting the loss for the year. Compared with 2024, the balance sheet contracted, as assets and equity declined while liabilities also decreased.